Use of TandemHeart As Bridge to Recovery for Antibody-Mediated Rejection in a Heart Transplant Patient
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
Antibody-mediated rejection is a major cause of graft failure, mortality, and morbidity among cardiac transplant recipients. We present the first reported case of TandemHeart (LivaNova, Pittsburgh, Pennsylvania) used in the management of antibody-mediated rejection associated with cardiogenic shock. ().
References
1.
Morales D, Braud B, Price J, Dreyer W, Denfield S, Clunie S
. Use of mechanical circulatory support in pediatric patients with acute cardiac graft rejection. ASAIO J. 2007; 53(6):701-5.
DOI: 10.1097/MAT.0b013e31815d68bf.
View
2.
Colvin M, Cook J, Chang P, Francis G, Hsu D, Kiernan M
. Antibody-mediated rejection in cardiac transplantation: emerging knowledge in diagnosis and management: a scientific statement from the American Heart Association. Circulation. 2015; 131(18):1608-39.
DOI: 10.1161/CIR.0000000000000093.
View
3.
Stendahl G, Berger S, Ellis T, Gandy K, Mitchell M, Tweddell J
. Humoral rejection after pediatric heart transplantation: a case report. Prog Transplant. 2010; 20(3):288-91.
DOI: 10.1177/152692481002000314.
View
4.
Kittleson M, Patel J, Moriguchi J, Kawano M, Davis S, Hage A
. Heart transplant recipients supported with extracorporeal membrane oxygenation: outcomes from a single-center experience. J Heart Lung Transplant. 2011; 30(11):1250-6.
DOI: 10.1016/j.healun.2011.05.006.
View
5.
Michaels P, Espejo M, Kobashigawa J, Alejos J, Burch C, Takemoto S
. Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease. J Heart Lung Transplant. 2003; 22(1):58-69.
DOI: 10.1016/s1053-2498(02)00472-2.
View